Cargando…
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification
Salivary duct carcinoma (SDC) is an uncommon, aggressive malignant neoplasm histologically resembling high-grade mammary ductal carcinoma. SDC can arise de novo or ex pleomorphic adenoma. To clarify the correlation of biomarker immunoprofile with clinicopathological findings and clinical outcome of...
Autores principales: | Takase, Soichiro, Kano, Satoshi, Tada, Yuichiro, Kawakita, Daisuke, Shimura, Tomotaka, Hirai, Hideaki, Tsukahara, Kiyoaki, Shimizu, Akira, Imanishi, Yorihisa, Ozawa, Hiroyuki, Okami, Kenji, Sato, Yuichiro, Sato, Yukiko, Fushimi, Chihiro, Okada, Takuro, Sato, Hiroki, Otsuka, Kuninori, Watanabe, Yoshihiro, Sakai, Akihiro, Ebisumoto, Koji, Togashi, Takafumi, Ueki, Yushi, Ota, Hisayuki, Hanazawa, Toyoyuki, Chazono, Hideaki, Osamura, Robert Yoshiyuki, Nagao, Toshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601711/ https://www.ncbi.nlm.nih.gov/pubmed/28938615 http://dx.doi.org/10.18632/oncotarget.19812 |
Ejemplares similares
-
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas
por: Shimura, Tomotaka, et al.
Publicado: (2017) -
Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients
por: Otsuka, Kuninori, et al.
Publicado: (2016) -
Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan
por: Kawakita, Daisuke, et al.
Publicado: (2016) -
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma
por: Hirai, Hideaki, et al.
Publicado: (2020) -
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy
por: Saigusa, Natsuki, et al.
Publicado: (2022)